OTHER
Aetiology
Concomitant use of proton pump inhibitors with clopidogrel may increase risk of readmission after discharge for acute MI
| The first 150 words of the full text of this article appear below. |
In older patients discharged from hospital after acute myocardial infarction (MI), does concomitant use of a proton pump inhibitor (PPI) with clopidogrel lead to adverse events?
population-based, nested, case–control study with 69-month follow-up.
Ontario, Canada.
13 636 patients who were
66 years of age (median age 76 y, 56% men) and had filled a prescription for clopidogrel within 3 days of hospital discharge after acute MI. Exclusion criteria were use of clopidogrel, ticlopidine, or dipyridamole in the year before admission; use of PPI combination products to eradicate Helicobacter pylori within 90 days of the index date (readmission for MI); or residence in a long-term care facility.
prescription records were used to assess exposure to PPIs within 30 days (current), 31–90 days (previous), and 91–180 days (remote) of the index date.
death or readmission for MI within 90 days of initial hospital discharge. Controls were matched to cases on age,
Duke Clinical Research Institute, Durham, North Carolina, USA
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
